BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 23873327)

  • 41. Effects of ranolazine on exercise tolerance and angina frequency in patients with severe chronic angina receiving maximally-tolerated background therapy: analysis from the Combination Assessment of Ranolazine In Stable Angina (CARISA) randomized trial.
    Sendón JL; Lee S; Cheng ML; Ben-Yehuda O;
    Eur J Prev Cardiol; 2012 Oct; 19(5):952-9. PubMed ID: 22689417
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ranolazine: a new option in the management of chronic stable angina.
    Dobesh PP; Trujillo TC
    Pharmacotherapy; 2007 Dec; 27(12):1659-76. PubMed ID: 18041887
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ranolazine. A metabolic modulator for the treatment of chronic stable angina.
    Anderson JR; Nawarskas JJ
    Cardiol Rev; 2005; 13(4):202-10. PubMed ID: 15949056
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina: results from the TERISA randomized clinical trial (Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina).
    Kosiborod M; Arnold SV; Spertus JA; McGuire DK; Li Y; Yue P; Ben-Yehuda O; Katz A; Jones PG; Olmsted A; Belardinelli L; Chaitman BR
    J Am Coll Cardiol; 2013 May; 61(20):2038-45. PubMed ID: 23500237
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ranolazine: new drug. Stable angina: not worth the risk.
    Prescrire Int; 2009 Aug; 18(102):148-7. PubMed ID: 19743543
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Utility of ranolazine in chronic stable angina patients.
    Patel PD; Arora RR
    Vasc Health Risk Manag; 2008; 4(4):819-24. PubMed ID: 19065998
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Medical therapy versus myocardial revascularization in chronic coronary syndrome and stable angina.
    Deedwania PC; Carbajal EV
    Am J Med; 2011 Aug; 124(8):681-8. PubMed ID: 21787900
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A pilot randomized study of ranolazine for reduction of myocardial damage during elective percutaneous coronary intervention.
    Pelliccia F; Pasceri V; Marazzi G; Rosano G; Greco C; Gaudio C
    Am Heart J; 2012 Jun; 163(6):1019-23. PubMed ID: 22709755
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Ranolazine in the treatment of chronic stable angina].
    Gustapane M; Cardillo MT; Biasillo G; Della Bona R
    Clin Ter; 2012; 163(3):231-4. PubMed ID: 22964698
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ranolazine and other antianginal therapies in the era of the drug-eluting stent.
    Berger P
    JAMA; 2004 Jan; 291(3):365-7. PubMed ID: 14734600
    [No Abstract]   [Full Text] [Related]  

  • 51. Improvement in left ventricular systolic and diastolic performance during ranolazine treatment in patients with stable angina.
    Figueredo VM; Pressman GS; Romero-Corral A; Murdock E; Holderbach P; Morris DL
    J Cardiovasc Pharmacol Ther; 2011 Jun; 16(2):168-72. PubMed ID: 20924097
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Update on evidence for treatment with ranolazine in stable angina.
    Carbone F; Montecucco F; Mach F
    Swiss Med Wkly; 2013; 143():w13874. PubMed ID: 24163124
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Management of myocardial ischemia. Is ranolazine needed? For all or some patients with myocardial ischemia?
    Cocco G
    Expert Opin Pharmacother; 2012 Dec; 13(17):2429-32. PubMed ID: 23121536
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ranolazine in patients with angina and coronary artery disease.
    Scirica BM; Morrow DA
    Curr Cardiol Rep; 2007 Jul; 9(4):272-8. PubMed ID: 17601393
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Spinal cord stimulation for refractory chronic angina pectoris: 100 patients treated in our 12-year experience].
    Fumero A; Lapenna E; Taramasso M; Alfieri O
    G Ital Cardiol (Rome); 2011 Sep; 12(9):599-605. PubMed ID: 21892221
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Spotlight on ranolazine in chronic stable angina pectoris.
    Siddiqui MA; Keam SJ
    Am J Cardiovasc Drugs; 2006; 6(5):357-9. PubMed ID: 17083271
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of ranolazine on cardiovascular system.
    Bonadei I; Vizzardi E; Quinzani F; Piovanelli B; Rovetta R; D'Aloia A; Cas LD
    Recent Pat Cardiovasc Drug Discov; 2011 Sep; 6(3):215-21. PubMed ID: 21867482
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A study of the effects of ranolazine using automated quantitative analysis of serial myocardial perfusion images.
    Venkataraman R; Belardinelli L; Blackburn B; Heo J; Iskandrian AE
    JACC Cardiovasc Imaging; 2009 Nov; 2(11):1301-9. PubMed ID: 19909934
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chronic angina and the treatment with ranolazine: facts and recommendations.
    Milne HC; Vallerand AH
    Prog Cardiovasc Nurs; 2009 Sep; 24(3):90-5. PubMed ID: 19737166
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ranolazine in patients with coronary artery disease.
    Scirica BM
    Expert Opin Pharmacother; 2007 Sep; 8(13):2149-57. PubMed ID: 17714067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.